PCIG
ONC

Partners Capital Investment Group’s BeOne Medicines Ltd ONC Stock Holding History

Partners Capital Investment Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Sell
4,395
-749
-15% -$221K 0.04% 106
2026
Q1 		$1.53M Sell
5,144
-600
-10% -$194K 0.06% 100
2025
Q4 		$1.75M Sell
5,744
-4,616
-45% -$1.51M 0.07% 96
2025
Q3 		$3.53M Hold
10,360
– – 0.14% 77
2025
Q2 		$2.51M Sell
10,360
-13,576
-57% -$3.33M 0.1% 89
2025
Q1 		$6.51M Buy
+23,936
New +$5.6M 0.11% 88
2024
Q4 		– Sell
-11,041
Closed -$2.48M – 172
2024
Q3 		$2.48M Sell
11,041
-1,338
-11% -$241K 0.04% 119
2024
Q2 		$1.77M Buy
+12,379
New +$1.91M 0.03% 132
2024
Q1 		– Sell
-15,316
Closed -$2.76M – 275
2023
Q4 		$2.76M Buy
+15,316
New +$2.77M 0.06% 115
2022
Q3 		– Sell
-18,311
Closed -$2.96M – 148
2022
Q2 		$2.96M Sell
18,311
-135,081
-88% -$21.1M 0.2% 70
2022
Q1 		$28.9M Buy
153,392
+36,794
+32% +$7.82M 1.42% 22
2021
Q4 		$31.6M Buy
116,598
+4,452
+4% +$1.5M 1.46% 26
2021
Q3 		$40.7M Sell
112,146
-800
-0.7% -$262K 1.86% 16
2021
Q2 		$38.8M Buy
112,946
+5,889
+6% +$1.95M 1.73% 17
2021
Q1 		$37.3M Buy
107,057
+55,267
+107% +$18.3M 1.63% 15
2020
Q4 		$13.4M Buy
51,790
+29,124
+128% +$8.02M 0.38% 56
2020
Q3 		$6.49M Sell
22,666
-2,535
-10% -$596K 0.4% 56
2020
Q2 		$4.75M Sell
25,201
-4,000
-14% -$651K 0.23% 65
2020
Q1 		$3.6M Hold
29,201
– – 0.25% 64
2019
Q4 		$4.84M Buy
+29,201
New +$4.85M 0.37% 58

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Partners Capital Investment Group's ONC Position: Q2 2026 in Review

Partners Capital Investment Group reduced its BeOne Medicines Ltd (ONC) stake by 15% in Q2 2026, selling an estimated $221K and leaving 4,395 shares worth $1.25M. The position accounts for 0.04% of the portfolio, ranked #106.

Partners Capital Investment Group first reported a position in ONC in Q4 2019 and has held it in 20 quarters since. The position peaked at $40.7M in Q3 2021. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Partners Capital Investment Group held 4,395 shares of BeOne Medicines Ltd worth $1.25M as of Q2 2026.
  • Partners Capital Investment Group sold 749 BeOne Medicines Ltd shares in Q2 2026, an estimated $221K.
  • BeOne Medicines Ltd made up 0.04% of Partners Capital Investment Group's portfolio in Q2 2026, its #106 holding.
  • Partners Capital Investment Group first reported a position in BeOne Medicines Ltd in Q4 2019 and has held it in 20 quarters since.
  • Partners Capital Investment Group's BeOne Medicines Ltd position peaked at $40.7M in Q3 2021.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Partners Capital Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.